{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:27:26Z","timestamp":1791404846567,"version":"4.3.3"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundamental Research Grant Scheme, Ministry of Education Malaysia","award":["FRGS\/1\/2018\/SKK02\/UKM\/03\/1"],"award-info":[{"award-number":["FRGS\/1\/2018\/SKK02\/UKM\/03\/1"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Avascular necrosis of bone (AVN) is increasingly being recognized as a complication of SLE and causes significant disability due to pain and mobility limitations. We studied the prevalence and factors associated with avascular necrosis (AVN) in a multiethnic SLE cohort. SLE patients who visited the outpatient clinic from October 2017 to April 2019 were considered eligible. Their medical records were reviewed to identify patients who developed symptomatic AVN, as confirmed by either magnetic resonance imaging or plain radiography. Subsequently, their SLE disease characteristics and treatment were compared with the characteristics of patients who did not have AVN. Multivariable logistic regression analyses were performed to determine the independent factors associated with AVN among the multiethnic SLE cohort. A total of 390 patients were recruited, and the majority of them were females (92.6%); the patients were predominantly of Malay ethnicity (59.5%), followed by Chinese (35.9%) and Indian (4.6%). The prevalence of symptomatic AVN was 14.1%, and the mean age of AVN diagnosis was 37.6 \u00b1 14.4 years. Both univariate and multivariable logistic regression analyses revealed that a longer disease duration, high LDL-C (low density lipoprotein cholesterol), positive anti-cardiolipin (aCL) IgG and anti-dsDNA results, a history of an oral prednisolone dose of more than 30 mg daily for at least 4 weeks and osteoporotic fractures were significantly associated with AVN. On the other hand, hydroxychloroquin (HCQ), mycophenolate mofetil (MMF) and bisphosphonate use were associated with a lower risk of AVN. No associations with ethnicity were found. In conclusion, several modifiable risk factors were found to be associated with AVN, and these factors may be used to identify patients who are at high risk of developing such complications. The potential protective effects of HCQ, MMF and bisphosphonates warrant additional studies.<\/jats:p>","DOI":"10.1371\/journal.pone.0248845","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T17:29:46Z","timestamp":1616174986000},"page":"e0248845","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-8114","authenticated-orcid":true,"given":"Syahrul Sazliyana","family":"Shaharir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Huoy","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozita","family":"Mohd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslinda","family":"Mustafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malehah Mohd","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Shuhaila","family":"Shahril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Shahrir Mohamed","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthiswary","family":"Rajalingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"pone.0248845.ref001","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/jama.1960.03030080028005","article-title":"Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus","volume":"174","author":"LC E. Dubois","year":"1960","journal-title":"J Am Med Assoc"},{"issue":"2","key":"pone.0248845.ref002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Y Assouline-Dayan","year":"2002","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"pone.0248845.ref003","first-page":"700","article-title":"A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors","volume":"35","author":"T Nevskaya","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"pone.0248845.ref004","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archinte.1978.03630290052018","article-title":"Aseptic Necrosis of Bone in Systemic Lupus Erythematosus: Relationship to Corticosteroid Therapy","volume":"138","author":"M Abeles","year":"1978","journal-title":"Arch Intern Med"},{"issue":"4","key":"pone.0248845.ref005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/0961203307076771","article-title":"Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus","volume":"16","author":"SC Fialho","year":"2007","journal-title":"Lupus"},{"issue":"5","key":"pone.0248845.ref006","first-page":"8085","article-title":"Non-corticosteroid-related risk factors for osteonecrosis in patients with systemic lupus erythematosus: a meta-analysis","volume":"9","author":"ZL Tao Wang","year":"2016","journal-title":"Int J Clin Exp Med"},{"issue":"11","key":"pone.0248845.ref007","doi-asserted-by":"crossref","first-page":"e0166270","DOI":"10.1371\/journal.pone.0166270","article-title":"Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide","volume":"11","author":"SS Shaharir","year":"2016","journal-title":"PLoS One"},{"key":"pone.0248845.ref008","first-page":"S536","article-title":"Risk factors for the development of avascular necrosis in pediatric systemic lupus erythematosus patients","volume":"65","author":"HY Reut Gurion","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"10","key":"pone.0248845.ref009","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00296-013-2783-3","article-title":"Organ damage in high-risk patients with systemic and incomplete lupus syndromes","volume":"33","author":"NJ Olsen","year":"2013","journal-title":"Rheumatol Int"},{"issue":"13","key":"pone.0248845.ref010","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/0961203313500547","article-title":"Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic","volume":"22","author":"V Golder","year":"2013","journal-title":"Lupus"},{"issue":"8","key":"pone.0248845.ref011","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"M Petri","year":"2012","journal-title":"Arthritis & Rheumatism."},{"key":"pone.0248845.ref012","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/CLEP.S143563","article-title":"Effects of chronic exposure of hydroxychloroquine\/chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseases","volume":"9","author":"L Fardet","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"8","key":"pone.0248845.ref013","first-page":"1521","article-title":"2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis & Rheumatology","volume":"69","author":"L Buckley","year":"2017"},{"issue":"277","key":"pone.0248845.ref014","first-page":"89","article-title":"Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy","author":"K Ono","year":"1992","journal-title":"Clin Orthop Relat Res"},{"issue":"8","key":"pone.0248845.ref015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/rheumatology\/37.8.895","article-title":"Risk factors for avascular bone necrosis in systemic lupus erythematosus","volume":"37","author":"CC Mok","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"7","key":"pone.0248845.ref016","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/0961203316676384","article-title":"Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus","volume":"26","author":"SM Tse","year":"2017","journal-title":"Lupus"},{"key":"pone.0248845.ref017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12969-015-0008-x","article-title":"Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature","volume":"13","author":"R Gurion","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"pone.0248845.ref018","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1046\/j.1523-1755.2002.00667.x","article-title":"Hospitalized avascular necrosis after renal transplantation in the United States","volume":"62","author":"KC Abbott","year":"2002","journal-title":"Kidney International"},{"issue":"7","key":"pone.0248845.ref019","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/RHU.0b013e3181ba3423","article-title":"Factors associated with osteonecrosis in Thai lupus patients: a case control study","volume":"15","author":"P Uea-areewongsa","year":"2009","journal-title":"J Clin Rheumatol"},{"issue":"Suppl. 1","key":"pone.0248845.ref020","first-page":"1","article-title":"Risk factors for avascular necrosis in patients with systemic lupus erythematosus","volume":"16","author":"X RQ LI","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"pone.0248845.ref021","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/ard.35.3.227","article-title":"Avascular necrosis in SLE. An apparent predilection for young patients","volume":"35","author":"FE Smith","year":"1976","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"pone.0248845.ref022","first-page":"136","article-title":"Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE","volume":"5","author":"J Dimant","year":"1978","journal-title":"J Rheumatol"},{"issue":"5","key":"pone.0248845.ref023","first-page":"352","article-title":"Avascular necrosis in systemic lupus erythematosus: clinical associations and a 47-year perspective","volume":"27","author":"L Cozen","year":"1998","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"2","key":"pone.0248845.ref024","first-page":"284","article-title":"Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus","volume":"20","author":"RA Asherson","year":"1993","journal-title":"J Rheumatol"},{"issue":"5","key":"pone.0248845.ref025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients","volume":"82","author":"R Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"pone.0248845.ref026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/096120339600500414","article-title":"Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?","volume":"5","author":"A Rascu","year":"1996","journal-title":"Lupus"},{"issue":"6","key":"pone.0248845.ref027","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.59.6.462","article-title":"Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: Is there a role for antiphospholipid antibodies?","volume":"59","author":"MY Mok","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"suppl_2","key":"pone.0248845.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex062.326","article-title":"LUPUS AND AVASCULAR NECROSIS OF THE BONE: HAS THE INCIDENCE IMPROVED?","volume":"56","author":"AN Jones","year":"2017","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"pone.0248845.ref029","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"I Ruiz-Arruza","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 10","key":"pone.0248845.ref030","article-title":"Avascular Necrosis Is Associated with APOL1 Variants in African Americans with Systemic Lupus Erythematosus","volume":"71","author":"K EE Yip","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"pone.0248845.ref031","first-page":"930","article-title":"MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus","volume":"62","author":"XY Yang","year":"2007","journal-title":"Pharmazie"},{"issue":"2","key":"pone.0248845.ref032","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 Nephropathy: From Genetics to Clinical Applications","volume":"16","author":"DJ Friedman","year":"2021","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"8","key":"pone.0248845.ref033","doi-asserted-by":"crossref","first-page":"e0182483","DOI":"10.1371\/journal.pone.0182483","article-title":"Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients","volume":"12","author":"A Blazer","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"pone.0248845.ref034","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/phgs.4.4.397.22747","article-title":"Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs","volume":"4","author":"T Sakaeda","year":"2003","journal-title":"Pharmacogenomics"},{"key":"pone.0248845.ref035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1874325001206010449","article-title":"Glucocorticoid-induced avascular bone necrosis: diagnosis and management","volume":"6","author":"KL Chan","year":"2012","journal-title":"Open Orthop J"},{"issue":"8538","key":"pone.0248845.ref036","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","article-title":"ACROSS-STUDY EVALUATION OF ASSOCIATION BETWEEN STEROID DOSE AND BOLUS STEROIDS AND AVASCULAR NECROSIS OF BONE","volume":"329","author":"D Felson","year":"1987","journal-title":"The Lancet"},{"issue":"11","key":"pone.0248845.ref037","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/rheumatology\/ker277","article-title":"Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study","volume":"50","author":"T Shigemura","year":"2011","journal-title":"Rheumatology"},{"issue":"4","key":"pone.0248845.ref038","first-page":"654","article-title":"Risk factors for osteonecrosis in systemic lupus erythematosus","volume":"24","author":"MA Mont","year":"1997","journal-title":"J Rheumatol"},{"issue":"1","key":"pone.0248845.ref039","first-page":"29","article-title":"Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus","volume":"17","author":"J Al Saleh","year":"2010","journal-title":"Egypt J Immunol"},{"issue":"3","key":"pone.0248845.ref040","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.10835","article-title":"Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging","volume":"48","author":"MG Tektonidou","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"3","key":"pone.0248845.ref041","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.transproceed.2011.02.072","article-title":"Avascular osteonecrosis and accompanying anemia, leucocytosis, and decreased bone mineral density in renal transplant recipients","volume":"43","author":"S Paydas","year":"2011","journal-title":"Transplant Proc"},{"issue":"7","key":"pone.0248845.ref042","first-page":"10133","article-title":"Alendronate prevents glucocorticoid-induced osteonecrosis of the femoral head in rats","volume":"10","author":"SW Junhui Yin","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"pone.0248845.ref043","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13018-019-1152-7","article-title":"Bisphosphonate combination therapy for non-femoral avascular necrosis","volume":"14","author":"S Agarwala","year":"2019","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"pone.0248845.ref044","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejr.2018.12.007","article-title":"Risk factors for osteonecrosis severity among Egyptian systemic lupus erythematosus patients: Magnetic resonance imaging (MRI) staging","volume":"41","author":"SMH Hamza","year":"2019","journal-title":"The Egyptian Rheumatologist"},{"issue":"4","key":"pone.0248845.ref045","first-page":"761","article-title":"Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus","volume":"28","author":"DD Gladman","year":"2001","journal-title":"J Rheumatol"},{"issue":"18","key":"pone.0248845.ref046","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/cncr.24474","article-title":"Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation","volume":"115","author":"S Campbell","year":"2009","journal-title":"Cancer"},{"issue":"386","key":"pone.0248845.ref047","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-200105000-00022","article-title":"Statin therapy decreases the risk of osteonecrosis in patients receiving steroids","author":"JW Pritchett","year":"2001","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"pone.0248845.ref048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12969-015-0008-x","article-title":"Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature","volume":"13","author":"R Gurion","year":"2015","journal-title":"Pediatric Rheumatology"},{"issue":"2","key":"pone.0248845.ref049","doi-asserted-by":"crossref","first-page":"e0212931","DOI":"10.1371\/journal.pone.0212931","article-title":"Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism","volume":"14","author":"R Felten","year":"2019","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T17:30:33Z","timestamp":1616175033000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248845"}},"subtitle":[],"editor":[{"given":"Stuart Barry","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0248845","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]}}}